Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence P Carter

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Behavioural Pharmacology|March 31, 2006
Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactoneWouter Koek, Lawrence P Carter, Huifang Wu, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 10, 2019
Pregnancy and Contraception Experiences in Women With Narcolepsy: A Narcolepsy Network SurveyMaeve Pascoe, Lawrence P Carter, Eveline Honig, et al.
Addiction (Abingdon, England)|April 5, 2012
What would menthol smokers do if menthol in cigarettes were banned? Behavioral intentions and simulated demandRichard J O'Connor, Maansi Bansal-Travers, Lawrence P Carter, et al.
Psychopharmacology|September 10, 2014
Inhaled vs. oral alprazolam: subjective, behavioral and cognitive effects, and modestly increased abuse potentialChad J Reissig, Joseph A Harrison, Lawrence P Carter, et al.
European Journal of Pharmacology|May 2, 2006
Discriminative stimulus effects of GHB and GABA(B) agonists are differentially attenuated by CGP35348Lawrence P Carter, Weibin Chen, Andrew Coop, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 2, 2006
Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHBLawrence P Carter, Brian D Richards, Miriam Z Mintzer, et al.
Psychopharmacology|October 26, 2012
Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteersLawrence P Carter, Bethea A Kleykamp, Roland R Griffiths, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|December 9, 2009
Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversionY Grace Wang, Todd J Swick, Lawrence P Carter, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|September 8, 2011
Sodium oxybate: updates and correction to previously published safety dataY Grace Wang, Todd J Swick, Lawrence P Carter, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 15, 2024
Phase 1 study of latozinemab in progranulin-associated frontotemporal dementiaMichael Ward, Lawrence P Carter, Julie Y Huang, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Behavioural Pharmacology|March 31, 2006
Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactoneWouter Koek, Lawrence P Carter, Huifang Wu, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 10, 2019
Pregnancy and Contraception Experiences in Women With Narcolepsy: A Narcolepsy Network SurveyMaeve Pascoe, Lawrence P Carter, Eveline Honig, et al.
Addiction (Abingdon, England)|April 5, 2012
What would menthol smokers do if menthol in cigarettes were banned? Behavioral intentions and simulated demandRichard J O'Connor, Maansi Bansal-Travers, Lawrence P Carter, et al.
Psychopharmacology|September 10, 2014
Inhaled vs. oral alprazolam: subjective, behavioral and cognitive effects, and modestly increased abuse potentialChad J Reissig, Joseph A Harrison, Lawrence P Carter, et al.
European Journal of Pharmacology|May 2, 2006
Discriminative stimulus effects of GHB and GABA(B) agonists are differentially attenuated by CGP35348Lawrence P Carter, Weibin Chen, Andrew Coop, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 2, 2006
Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHBLawrence P Carter, Brian D Richards, Miriam Z Mintzer, et al.
Psychopharmacology|October 26, 2012
Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteersLawrence P Carter, Bethea A Kleykamp, Roland R Griffiths, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|December 9, 2009
Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversionY Grace Wang, Todd J Swick, Lawrence P Carter, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|September 8, 2011
Sodium oxybate: updates and correction to previously published safety dataY Grace Wang, Todd J Swick, Lawrence P Carter, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 15, 2024
Phase 1 study of latozinemab in progranulin-associated frontotemporal dementiaMichael Ward, Lawrence P Carter, Julie Y Huang, et al.
Pageof 5